Align Technology is expected to report Q3 2026 revenue of $1.01 billion and non-GAAP EPS of $2.32, with the current stock price of $154.51 trading well below the $195.40 average analyst target.
Investors are primarily focused on Clear Aligner case volume, specifically whether robust international growth can offset persistent demand weakness in the North American adult dental segment.
Recent performance has been pressured by double-digit declines in imaging systems revenue as practices shift toward lower-cost scanner models and leasing agreements. Markets will closely monitor updates on the iTero Lumina rollout and expansion into the teen market to gauge the sustainability of long-term growth targets.